BQ.1.1, XBB.1, and XBB.1.5 neutralization after bivalent mRNA COVID-19 booster in patients with cancer
Sidse Ehmsen, Rune M. Pedersen, Line L. Bang, Anders Asmussen, Amalie Kragh, Dorte Kinggaard Holm, Thomas Vognbjerg Sydenham, Thøger Gorm Jensen, Stefan Starup Jeppesen, Henrik Frederiksen, Thomas Emil Andersen, Henrik J. Ditzel
Topics & Concepts
Bivalent (engine)Coronavirus disease 2019 (COVID-19)Booster (rocketry)NeutralizationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyMessenger RNACancer researchMedicineBiologyMolecular biologyChemistryGeneticsInternal medicineGeneVirusInfectious disease (medical specialty)OutbreakPhysicsDiseaseOrganic chemistryMetalAstronomySARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCAR-T cell therapy research